Homology Medicines Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Accomplishments

NEXT STORY
Molecular Templates, Inc. Reports Fourth Quarter 2019 Financial Results
PREV STORY
Chembio Diagnostics Reports Fourth Quarter and Full Year 2019 Financial Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Meridian Bioscience Announces Preliminary Revenue Results for Fiscal 2021 Third Quarter

author_avatar
NASDAQ Market News

AIT Therapeutics Reports Second Quarter 2017 Financial Results

REHOVOT, Israel and NEW YORK, Aug. 11, 2017 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. ...

author_avatar
NASDAQ Market News

Immune Design Presents Data on the Mechanism of Action of G100 via TLR4 Expressed in B Cell Malignancies at the Inaugural AACR International Meeting Advances in Malignant Lymphoma

- G100 directly targets and modifies TLR4 expressing malignant B cells making them more ...

author_avatar
NASDAQ Market News